Antipsychotic drug effects in a model of schizophrenic attentional disorder: A randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people

Biological Psychiatry

Volumn 40, Issue 11, 1996, Pages 1135-1143

  Williams, Jonathan H ^a   Wellman, Nigel A ^a   Geaney, David P ^a   Cowen, Philip J ^a   Feldon, Joram ^b   Rawlins, J N P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Institute of Pharmacology and Toxicology   (Switzerland)

Author keywords

attention; haloperidol; healthy volunteers; latent inhibition; randomized controlled trial; schizophrenia

Indexed keywords

HALOPERIDOL;

ADULT; ARTICLE; ATTENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LATENT INHIBITION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SCHIZOPHRENIA;

EID: 0030560888     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(95)00629-X     Document Type: Article

References (55)

1. Allan LM, Williams JH, Wellman NA, Tonin J, Taylor E, Rawlins JNP (1995): Effects of tobacco smoking, schizotypy and number of pre-exposures on latent inhibition in healthy subjects. Personality Individual Differences 19:893-902.
2. Angrist B, Rotrosen J, Gershon S (1980): Differential effects of amphetamine and neuroleptics vs. positive symptoms in schizophrenia. Psychopharmacology 72:17-19.
3. Anscombe R (1987): The disorder of consciousness in schizophrenia. Schizophr Bull 13:241-260.
4. Baruch I, Hemsley DR, Gray JA (1988a): Differential performance of acute and chronic schizophrenics on a latent inhibition task. J Nerv Ment Dis 176:598-606.
5. Baruch I, Hemsley DR, Gray JA (1988b): Latent inhibition and "psychotic-proneness" in normal subjects. Personality Individual Differences 9:777-784.
6. Beech A, Powell T, McWilliam J, Claridge G (1989a): Evidence of reduced cognitive inhibition in schizophrenia. Br J Clin Psychol 28:109-116.
7. Beech A, Baylis GC, Smithson P, Claridge G (1989b): Individual differences in schizotypy are reflected in measures of cognitive inhibition. Br J Clin Psychol 28:117-129.
8. Bleuler E (1913): Dementia praecox or the group of schizophrenias. Translated into English, 1987, in Cutting J, Shepherd M (eds), The Clinical Roots of the Schizophrenia Concept. Cambridge University Press. Cambridge, U.K. pp. 59-74.
9. Bogerts B (1993): Recent advances in the neuropathology of schizophrenia. Schizophr Bull 19:431-445.
10. Bogerts B, Meertz E, Schonfeldt-Bausch R (1985): Basal ganglia and limbic system pathology in schizophrenia. Arch Gen Psychiatry 42:784-791.
11. Bouton ME (1993): Context, time and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull 114:80-99.
12. Christison GW, Atwater GE, Dunn LA, Kilts CD (1988): Haloperidol enhancement of latent inhibition: Relation to therapeutic action? Biol Psychiatry 23:746-749.
13. Claridge G (1978): Animal models of schizophrenia: The case for LSD-25. Schizophr Bull 4:186-209.
14. Claridge GS, Broks P (1985): Schizotypy and hemisphere function: I. Theoretical considerations and measurement of schizotypy. Personality Individual Differences 5:633-648.
15. Connell PH (1958): Amphetamine Psychosis. Maudsley Monograph 5. Oxford: Oxford University Press.
16. Crider A, Solomon PR, McMahon MA (1982): Disruption of selective attention in the rat following d-amphetamine administration: Relationship to schizophrenic attention disorder. Biol Psychiatry 17:351-361.
17. Diaconis P, Efron B (1983): Computer-intensive methods in statistics. Sci Am May, 248:96-108.
18. Dunn LA, Atwater G, Kilts CD (1993): Effects of antipsychotic drugs on latent inhibition: Sensitivity and specificity of an animal behavioural model of clinical drug action. Psychopharmacology 112:315-323.
19. Efron B (1979): Bootstrap methods: Another look at the jackknife. Ann Stat 7:1-26.
20. Efron B (1981): Non-parametric estimates of standard error: The jackknife, the bootstrap and other methods. Biometrika 68: 589-599.
21. Ellenbrook BA, Cools AR (1990): Animal models with construct validity for schizophrenia. Behav Pharmacol 1:469-490.
22. Eysenck HJ, Eysenck SBG (1975): Manual of the Eysenck Personality Questionnaire. London: Hodder & Stoughton.
23. Eysenck HJ, Eysenck SBG (1976): Psychoticism as a Dimension of Personality London: Hodder & Stoughton.
24. Feldon J, Weiner I (1991a): An animal model of attentional deficit. In Boulton AA et al (eds), Neuromethods, vol 18, Animal Models in Psychiatry. Clifton, NJ: Humana Press. pp. 316-361.
25. Feldon J, Weiner I (1991b): The latent inhibition model of schizophrenic attention disorder: Haloperidol and sulpiride increase rats' ability to ignore irrelevant stimuli. Biol Psychiatry 29:635-646.
26. Feldon J, Weiner I (1992): From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. J Psychiatr Res 26:345-366.
27. Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD (1991): The neuropsychology of schizophrenia. Behav Brain Sci 14:1-84.
28. Gray NS, Hemsley DR, Gray JA (1992a): Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol Psychiatry Brain Res 1:83-89.
29. Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA (1992b): Abolition of latent inhibition by a single 5 mg dose of D-amphetamine in man. Psychopharmacology 107:425-430.
30. Janssen P, Niemegeers C, Schellekens K (1967): Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillisers) from animal data? Part IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-induced "chewing" and "agitation" in rats. Arzneimittelforschung Drug Res 17:841-854.
31. Joseph MH, Jones SH (1992): Latent inhibition and blocking: Further considerations of their construct validity as animal models of schizophrenia. Behav Pharmacol 2:521-526.
32. Killcross AS, Dickinson A, Robbins TW (1991a): Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: Implications for animal models of schizophrenia attentional dysfunction. Psychopharmacology 115:185-195.
33. Killcross AS, Dickinson A, Robbins TW (1991b): Effects of the neuroleptic a-flupenthixol on latent inhibition in aversively and appetitively-motivated paradigms: Evidence for dopamine-reinforcer interactions. Psychopharmacology 115:196-205.
34. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RSJ (1992): Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160:179-186.
35. Lubow RE (1973): Latent inhibition. Psychol Bull 79:398-407.
36. Lubow RE (1989): Latent Inhibition and Conditioned Attention Theory. CUP. Cambridge, UK: Cambridge University Press.
37. Lubow RE, Gewirtz JC (1995): Latent inhibition in humans: Data, theory and implications for schizophrenia. Psychol Bull 117:87-103.
38. Lubow RE, Moore AU (1959): Latent inhibition: The effect of non-reinforced exposure to the conditioned stimulus. J Comp Physiol Psychol 52:464-467.
39. Lyon M (1991): Animal models with parallels to schizophrenia. In Boulton AA, Baker GB, Martin-Iverson MT (eds), Animal Models in Psychiatry. Clifton, NJ: Humana Press, ch. 3.
40. MacDonald N (1960): The other side: Living with schizophrenia. Can Med Assoc J 82:218-221.
41. Matthysse S (1986): Animal models in psychiatry. Prog Brain Res 65:259-270.
42. Nestor PG, Faux SF, McCarley RW, Sands SF (1991): Neuroleptics improve sustained attention in schizophrenia: A study using signal detection theory. Neuropsychopharmacology 1:145-149.
43. Pakkenberg B (1990): Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens of schizophrenics. Arch Gen Psychiatry 47:1023-1028.
44. Schmajuk NA (1987): Animal models of schizophrenia: The hippocampally-lesioned animal. Schizophr Bull 12:317-327.
45. Solomon PR, Staton DM (1982): Differential effects of micro-injections of d-amphetamine into the nucleus accumbens or caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol Psychiatry 17:743-756.
46. Solomon PR, Crider A, Winkelman JW, Tun A, Kamer RH, Kaplan LJ (1981): Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: Relation to chronic attention disorder. Biol Psychiatry 16:519-537.
47. Still AW, White AP (1981): The approximate randomization test as an alternative to the F test in analysis of variance. Br J Math Stat Psychol 34:243-252.
48. Tai CT, Cassaday HJ, Feldon J, Rawlins JNP (1995): Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats. Neurobiol Learning Memory 64:36-48.
49. Weiner I, Feldon J (1987): Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology 83:248-253.
50. Weiner I, Lubow RE, Feldon J (1981): Chronic amphetamine and latent inhibition. Behav Brain Res 2:285-286.
51. Weiner I, Lubow RE, Feldon J (1984): Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 83:194-199.
52. Weiner I, Feldon J, Katz Y (1987): Facilitation of the expression but not of the acquisition of latent inhibition by haloperidol in rats. Pharmacol Biochem Behav 26:241-246.
53. Weiner I, Lubow RE, Feldon J (1988): Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30:871-878.
54. Weiner I, Smith AD, Rawlins JNP, Feldon J (1992): A neuroleptic-like effect of ceronapril on latent inhibition. Neuroscience 49:307-315.
55. Yee B, Feldon J, Rawlins JNP (1995): Latent inhibition in rats is abolished by NMDA-induced neuronal loss in the retrohippocampal region but this lesion effect can be prevented by systemic haloperidol. Behav Neurosci 10:227-240.